cellular
• abnormal appearance young spermatocytes and possibly degenerating central mass of cells at 15.5 postnatal days
|
growth/size/body
• increased body weight in female after 6 months of age
• normal body weight in female up to 60 postnatal days
• normal body weight in male
|
reproductive system
• abnormal appearance young spermatocytes and possibly degenerating central mass of cells at 15.5 postnatal days
|
• absence of corpora lutea at 2 months
|
• many atretic follicles at 2 months
|
• follicles advance only rarely to the early antral stage at 2 months
|
• decreased ovaries weight in 2-month-old mice (23% of those of sex matched wild-type littermates)
|
thin uterus
(
J:158384
)
• thread-like uterus
|
• pin point openings
|
• reduced anal-genital distance in male
|
• reduced size of the preputial gland
|
small penis
(
J:158384
)
• small genital papilla in male
|
• reduced size of the androgen-dependent seminal vesicle
|
• a central mass of cells is difficult to identify and many are possibly degenerating at 10.5 postnatal days
• the smaller cord contains a peripheral layer of Sertoli cell nuclei and spermatogonia at 10.5 and 15.5 postnatal days
• no lumen formation at 15.5 postnatal days and 2 months of age
• testosterone-treated null males (n=3) have elongated spermatids and a lumen
|
• smaller cord starting from 10.5 postnatal days
|
small testis
(
J:158384
)
• smaller testis starting from 10.5 postnatal days
|
• decreased testis weight in 2-month-old mutants (only 3% of those of wild-type littermates)
• testosterone-treated null males (n=3) have testes weight increased to 54% of sham implanted WT males (n=4)
|
• reduced size of the epididymis
|
• delayed vaginal opening (41.4 vs 34.6)
• in about 25%of null mice, the vagina is not open even by 6 months of age
|
• no estrous cycles
|
homeostasis/metabolism
• decreased serum testosterone level in male (0.1 vs 0.7 ng/ml)
|
• decreased serum estradiol level in female (10.0 vs 30.7 pg/ml)
|
• decreased serum FSH level in male (3.4 vs 33.5 ng/ml) and female (2.3 vs 8.0 ng/ml)
|
• undetectable serum LH levels in male and female (<0.048 ng/ml)
|
• decreased serum progesterone level in female (3.2 vs 9.4 ng/ml)
|
renal/urinary system
• reduced size of the preputial gland
|
small penis
(
J:158384
)
• small genital papilla in male
|
endocrine/exocrine glands
• reduced size of the preputial gland
|
• reduced size of the androgen-dependent seminal vesicle
|
• absence of corpora lutea at 2 months
|
• many atretic follicles at 2 months
|
• follicles advance only rarely to the early antral stage at 2 months
|
• decreased ovaries weight in 2-month-old mice (23% of those of sex matched wild-type littermates)
|
• a central mass of cells is difficult to identify and many are possibly degenerating at 10.5 postnatal days
• the smaller cord contains a peripheral layer of Sertoli cell nuclei and spermatogonia at 10.5 and 15.5 postnatal days
• no lumen formation at 15.5 postnatal days and 2 months of age
• testosterone-treated null males (n=3) have elongated spermatids and a lumen
|
• smaller cord starting from 10.5 postnatal days
|
small testis
(
J:158384
)
• smaller testis starting from 10.5 postnatal days
|
• decreased testis weight in 2-month-old mutants (only 3% of those of wild-type littermates)
• testosterone-treated null males (n=3) have testes weight increased to 54% of sham implanted WT males (n=4)
|
integument
• reduced size of the preputial gland
|